Wided Najahi-Missaoui Granted First Women in Pharma Scholarship
The Women in Pharma (WIP) Networking Community launched its first education series at the ISPE 2016 Annual Meeting & Expo. Thank you Fran Zipp and Charlotte Enghave Fruergaard for leading this important initiative. One goal for this group was to fund a scholarship through the sale of Women in Pharma lapel pins. Since the inaugural event took place at our conference in Atlanta, Georgia, we dedicated the first Women in Pharma Scholarship to a student at University of Georgia (UGA).
I am very pleased to share that Wided Najahi-Missaoui was granted the ISPE’s first Women in Pharma Scholarship. She is currently a fifth-year doctoral student at UGA, investigating nanoparticulate drug delivery systems such as liposomes to target therapies for prostate and breast cancer. Her overall goal is to integrate the pathophysiology of cancer with the pharmacology of these drug delivery systems to develop more efficient targeted cancer therapies.
Join myself and Wided Najahi-Missaoui at the ISPE 2017 Annual Meeting & Expo in San Diego, California where we are proud to host two sessions dedicated to the success of Women in Pharma. Key female executives in the pharmaceutical industry will lead these sessions focusing on professional development and technical knowledge.
We are thrilled to share our new interactive website!
This newly redesigned website was crafted to provide our Members and potential Members with an interactive, fluid means to access all that ISPE has to offer—incorporating streamlined navigation, clear design, and a responsive layout.
John Bournas, ISPE CEO and President, said it best, “As ISPE’s global presence continues to thrive, we want our website to reflect that growth. Our team worked diligently to craft a website that would be truly beneficial to all of our visitors worldwide, creating an advanced, informative, and easy to navigate channel to access our full spectrum of resources and benefits.”
We hope you enjoy exploring ISPE’s new website, learning more about our full spectrum of resources available to support your professional initiatives and those of the pharmaceutical manufacturing industry.
Senior Director, Strategic Partnerships & Past ISPE Board Chair
Pfizer Global Clinical Supplies
Michael A. Arnold is Senior Director of Strategic Partnerships and Investigational Products Business Process Owner for Pfizer's Global Clinical Supply Chain. In this capacity he...
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.